DMAAR

Price Data

Drugs Made In America Acquisition Corp. (DMAAR) is a special purpose acquisition company (SPAC) focused on merging with innovative pharmaceutical firms in the United States. With the dual objectives of addressing increasing healthcare demands and mitigating global supply chain disruptions, DMAAR aims to promote cost-effective drug manufacturing solutions that strengthen the domestic pharmaceutical industry. Guided by a seasoned management team, the company is well-positioned to capitalize on growth opportunities in the sector, delivering sustainable value to shareholders while revitalizing American healthcare manufacturing.